Xenon Pharmaceuticals
XENE
#3702
Rank
ยฃ2.58 B
Marketcap
ยฃ33.50
Share price
-0.88%
Change (1 day)
1.58%
Change (1 year)

Revenue for Xenon Pharmaceuticals (XENE)

Revenue in 2025 (TTM): ยฃ5.8 Million

According to Xenon Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ5.63 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Xenon Pharmaceuticals from 2014 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ5.8 M
2024 N/A
2023 N/A-100%
2022 ยฃ7.79 M-42.91%
2021 ยฃ13.65 M-42.12%
2020 ยฃ23.59 M353.13%
2019 ยฃ5.2 M
2018 N/A-100%
2017 ยฃ0.23 M-84.25%
2016 ยฃ1.46 M-86.1%
2015 ยฃ10.51 M-42.32%
2014 ยฃ18.22 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Coherus BioSciences
CHRS
ยฃ62.75 M 1,014.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Atara Biotherapeutics
ATRA
ยฃ0.14 B 2,415.56%๐Ÿ‡บ๐Ÿ‡ธ USA